Back to Search
Start Over
Supplementary Figure 2 from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure 2
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2904c5ffb104f34aa297ea68c6f981a0
- Full Text :
- https://doi.org/10.1158/1078-0432.22474877